Tania Farooq2025-06-01T20:10:51+05:00As Pakistan's pharmaceutical sector evolves rapidly post-deregulation, AGP Limited (AGP) stands out as one of the most attractive investment opportunities. With a strong product mix,...
Tania Farooq2025-06-01T20:09:20+05:00Pakistan’s pharmaceutical sector has quietly morphed into a compelling value play. Despite major regulatory relief, margin expansion, and earnings growth, valuations across the board remain...
Tania Farooq2025-05-31T00:17:25+05:00Lalpir Power Ltd. (LPL) is entering a transformative phase in its operational journey. The company, which operates a 362MW residual fuel oil (RFO)-based steam turbine...
Tania Farooq2025-05-30T16:24:54+05:00Image Pakistan Ltd. (IMAGE) is stitching together a strong growth narrative in the retail fashion space, underpinned by strategic investments, rising demand, and a deeply...
Tania Farooq2025-05-30T16:21:52+05:00Pakistan’s pharmaceutical sector is undergoing a transformation. A combination of regulatory liberalization and long-term demographic trends is setting the stage for sustained growth, making it...
Tania Farooq2025-05-30T16:19:01+05:00Pakistan’s pharmaceutical sector has entered a phase of structural transformation, and one question stands out: Can local drug manufacturers truly outperform multinational companies (MNCs)? Based...
Tania Farooq2025-05-30T12:49:14+05:00Abbott Laboratories (Pakistan) Ltd, (ABOT) one of the country’s top multinational pharmaceutical players, is taking a bold step to reintroduce several previously discontinued products. This...
Tania Farooq2025-05-30T12:45:15+05:00In Pakistan’s evolving pharmaceutical landscape, few brands hold as dominant a position as Panadol. Now, Haleon Pakistan Ltd (HALEON) is doubling down on this flagship...
Tania Farooq2025-05-29T18:20:04+05:00Pakistan Aluminium Beverage Cans Limited (PABC), the country’s first and only manufacturer and exporter of aluminium beverage cans, reported a resilient performance for CY24 and...
Tania Farooq2025-05-29T18:11:23+05:00Pak Elektron Limited (PAEL) is revving up for a significant year. With a target gross revenue of Rs95 billion in CY25—36% growth year-over-year—the company is...